Flexible and Semi-Rigid Ureteroscopy Market Size was valued at USD 0.68 Billion in 2023. The Flexible and Semi-Rigid Ureteroscopy market Product is projected to grow from USD 0.71 Billion in 2024 to USD 1.05 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.88% during the forecast period (2024 - 2032). The disease of urolithiasis is becoming more common, and the number of elderly people is growing quickly, are the key market drivers enhancing the market growth.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
May 2023: Boston Scientific announced that it was putting $300 million into the expansion of its Galway, Ireland plant expected to add 400 jobs (Olympus Global).
March 2023: In addition, the FDA approved this product as being suitable for use during treatment of kidney stones by doctors who have since used it for this purpose in at least two treatments (Olympus Global).
January 2023: Besides, Boston Scientific has just finished its acquiring of Apollo Endosurgery, which has blostered its endoluminal surgery capabilities (Olympus Global).
In February 2023, Olympus Corporation also launched their flexible ureteroscope model called EVIS Flex-Q. The scope is designed to be more flexible and easier to manoeuvre than previous models.
Dornier MedTech also introduced its new Axis single-use digital flexible ureteroscope in January 2023. The scope is designed to give better visuals and images when performing ureteroscopic procedures.
September 2022: The launch of EXALT™ Model B Single-Use Bronchoscope by the company for bronchoscopy procedures (Olympus Global).
Boston Scientific’s acquisition of Lumenis Ltd.’s surgical business was concluded in August 2022, thereby expanding their portfolio in laser systems for urology and otolaryngology as well as other surgical operations or diseases-related applications like ENT surgeries used across various hospitals within urology.
December 2021: After being granted designation as South Korea’s latest breakthrough device from the Ministry of Food and Drug Safety (MFDS), Easyendo Surgical Inc. will introduce a roboticized ureteroscope into the market.
Urolithiasis affects about 15% of people worldwide at some point in their lives. It affects people of all races, sexes, and ages, but it is more prevalent in men between the ages of 20 and 49. Ureteroscopy is crucial in this situation because it significantly affects how patients with urolithiasis are managed. As a result, it is regarded as the primary form of treatment for urinary tract stones. The primary treatments for ureteral stones, tumours, and strictures include ureteroscopy, a safe and effective test. Due to technology developments like single-use flexible ureteroscopes and application diversification, its use has considerably increased over time.
The ureter and kidney can now be more easily accessed via the urethra thanks to technological developments in ureteroscope size and design, which negates the need for any surgical incisions. Furthermore, semi-rigid and flexible ureteroscopes make it simple to examine practically every area of the urinary tract, and high-quality digital optics enable precise evaluation of mucosal lesions and stones. There are few contraindications for using ureteroscopes, which is one of their main advantages. Additionally, ureteroscopes' functions have lately expanded, primarily as a result of the increased incidence of obesity, bleeding disorders, and paediatric stone disease. Obesity prevalence is at an all-time high, and obese people have been found to have a higher than average risk of acquiring kidney stones. As a result, the market for flexible and semi-rigid ureteroscopy is expected to rise even faster. Other procedures like shock wave lithotripsy or percutaneous nephrolithotomy frequently fail and have a higher anaesthetic risk. As a result, ureteroscopy is frequently seen to be the best option for people who are obese. Over the course of the projection period, this aspect may further fuel market growth.
The rising prevalence of urinary tract infections, particularly in developed nations, is one of the key factors driving the flexible & semi-rigid ureteroscopy market trends. 40 percent of American women are predicted to experience a UTI at some point in their lifetime, according to data from StatPearls. The prevalence of the condition will increase the demand for flexible and semi-rigid ureteroscopes since UTIs can increase the danger of kidney stones. Additionally, the emphasis on the adoption of systematic approaches to the treatment of chronic kidney disease and the expanding older population sensitive to urinary disorders will improve industry dynamics in the near future. Thus, driving the Flexible and Semi-Rigid Ureteroscopy market revenue.
The Flexible and Semi-Rigid Ureteroscopy market segmentation, based on product, includes flexible ureteroscopes, fiberoptic ureteroscopes, digital ureteroscopes, semi-rigid ureteroscopes, and rigid ureteroscopes. Flexible ureteroscopes segment dominated the market in 2022. This is due to the product's widespread use. The best method for treating various kidney and ureter stones is thought to be flexible ureteroscopes.
The Flexible and Semi-Rigid Ureteroscopy market segmentation, based on application, includes therapeutic applications and diagnostic applications. Therapeutic applications segment dominated the market in 2022. The increased incidence of kidney stones is mostly to blame for this.
The Flexible and Semi-Rigid Ureteroscopy market segmentation, based on end user, includes hospitals and clinics, ambulatory surgical centers, diagnostic centers, research centers, and others. Hospitals and clinics segment dominated the Flexible and Semi-Rigid Ureteroscopy market in 2022. Due of convenient access, hospitals do the majority of diagnostic testing. Over the forecast period, it is expected that this aspect will favour the segment's growth.
Figure 1 Flexible and Semi-Rigid Ureteroscopy Market, by End User, 2023 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Flexible and Semi-Rigid Ureteroscopy Market dominated this market in 2022 (45.80%). The existence of large market participants like Boston Scientific, Stryker, and Elmed Medical Systems is one of the key reasons for their sustained supremacy. In terms of ureteroscope utilisation, North America is the region with the most experience. Other elements contributing to the region's sustained supremacy include patient awareness, an established healthcare infrastructure, and the availability of cutting-edge equipment. Further, the U.S. Flexible and Semi-Rigid Ureteroscopy market held the largest market share, and the Canada Flexible and Semi-Rigid Ureteroscopy market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 FLEXIBLE AND SEMI-RIGID URETEROSCOPY MARKET SHARE BY REGION 2023 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Flexible and Semi-Rigid Ureteroscopy market accounted for the healthy market share in 2022. This is a result of the ageing population's increased propensity for urological and renal conditions. According to Eurostat data, the number of people 65 and older in the EU-27 will rise from 90.5 million in 2019 to 129.8 million by 2050. Additionally, the increased investment in bolstering healthcare infrastructure will speed the development of ureteroscopes in the area. Further, the German Flexible and Semi-Rigid Ureteroscopy market held the largest market share, and the U.K Flexible and Semi-Rigid Ureteroscopy market was the fastest growing market in the European region
The Asia Pacific Flexible and Semi-Rigid Ureteroscopy market is expected to register significant growth from 2024 to 2032. This is caused by the rising prevalence of urolithiasis and the rising elderly population. Additionally, the regional market is anticipated to be driven in the coming years by the need for improved diagnosis and significant unmet clinical needs. Moreover, China’s Flexible and Semi-Rigid Ureteroscopy market held the largest market share, and the Indian Flexible and Semi-Rigid Ureteroscopy market was the fastest growing market in the Asia-Pacific region.
Flexible and Semi-Rigid Ureteroscopy Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Flexible and Semi-Rigid Ureteroscopy market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Flexible and Semi-Rigid Ureteroscopy Industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Flexible and Semi-Rigid Ureteroscopy Industry to benefit clients and increase the market sector. In recent years, the Flexible and Semi-Rigid Ureteroscopy Industry has offered some of the most significant advantages to medicine. Major players in the Flexible and Semi-Rigid Ureteroscopy market, including Stryker, Olympus Corporation, Boston Scientific, Richard Wolf, KARL STORZ, ELMED Medical Systems, Maxer Endoscopy, Rocamed, Vimex Endoscopy, and ProSurg, are attempting to increase market demand by investing in research and development operations.
Gyrus ACMI LP offers medical equipment. The business offers energy systems and medical visualisation. Customers of Gyrus ACMI are located in the US. Gyrus ACMI USA started research on secondary deflection ureteroscopes in January 2018, which advanced the technique for quick and simple treatment procedures. Gyrus ACMI, USA's Elite ureteroscope includes secondary deflection, enabling the surgeon to reach a total deflection angle of up to 270°. The wide range of deflection capabilities and "S" form of the ureteroscope, among other advantageous features, enable the urologist to access any intrarenal collecting system area.
Manufacturer of optical and digital precision equipment and tools is Olympus Corp (Olympus). The business creates, produces, and sells tools and gadgets for the medical, healthcare, imaging, information, and other commercial areas. It provides scientific solutions like laser scanning microscopes, industrial and biological microscope systems, remote visual inspection products, and non-destructive testing systems, as well as medical systems like endotherapy devices, endoscopes, and endoscopy products to assist healthcare professionals in treating patients. Additionally, it provides services for system development and biological materials. The business has operations in the Americas, Europe, and Asia-Pacific through its subsidiaries and facilities. Japan's Tokyo is home to Olympus Corp. The treatment of ureteral cannulation has advanced thanks to a study on ureteroscopes with an evolved tip that Olympus Corporation launched in Japan in May 2018.
Key Companies in the Flexible and Semi-Rigid Ureteroscopy market include
Flexible and Semi-Rigid Ureteroscopy Industry Developments
February 2023 The FDA has given Boston Scientific's lithovueTM elite single-use digital flexible ureteroscope system approval. It is the first ureteroscope system to allow real-time monitoring of intrarenal pressure during ureteroscopy treatments.
April 2019 The AXIS single-use digital flexible ureteroscope was unveiled by Dorner MedTech.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)